|
Drug name | Mode of action | Modification type | Examples | Usual route of administration | Targeted brain tumor type | Reference |
|
Temozolomide |
Alkylating agent |
Nanoparticle based | Polysorbate-80 coated PBCA nanoparticles as feasible carrier for TMZ delivery to the brain | | | [193] |
Transferrin-appended PEGylated nanoparticles for TMZ delivery to brain | | | [194] |
TMZ solid lipid nanoparticles (TMZ-SLNs) | Oral | Glioblastoma multiforme | [195] |
Polysorbate-80 coated TMZ loaded PLGA based supermagnetic nanoparticles | | | [196] |
TMZ loaded in PLGA nanoparticle | | | [197] |
TMZ loaded in chitosan nanoparticle | | | [198] |
TMZ loaded in albumin nanoparticle | | | [199] |
|
Carmustine (BCNU) |
Alkylating agent | Liposomes, polymer microchips, and microspheres | Gliadel | | | [200] |
Nanoparticles | Chitosan surface-modified poly(lactide-co-glycolide) nanoparticles loaded with BCNU | Wafer implant/IV/oral | Glioblastoma multiforme, medulloblastoma, and low grade astrocytoma | [201] |
Catanionic solid lipid nanoparticles (CASLNs) carrying BCNU | [202] |
BCNU-loaded poly(lactic acid) (PLA) nanoparticle | [203] |
|
Doxorubicin (DOX) |
Anthracyclines, inhibiting nucleic acid synthesis | Liposome | Long-circulating PEGylated liposomes to cross blood brain barrier | | | [204] |
Nanoparticle | Cationic solid lipid nanoparticles (CASLNs), loaded with DOX | IV | Glioblastoma multiforme | [205] |
Human serum albumin nanoparticles loaded with DOX | | | [206] |
|
Lomustine (CCNU) | Alkylating nitrosourea compound | Liposomes or microcapsules | Administration of CCNU-Lips and inclusion complex solution of CCNU with hydroxypropyl-β-cyclodextrin (CCNU-Sol) | Oral | Oligodendrogliomas and mixed oligoastrocytomas | [207] |
|
Vincristine (Oncovin) | Vinca alkaloid | Liposome | Vincristine sulfate liposome, PEGylated liposome | IV | Anaplastic oligoastrocytoma and oligodendroglioma, metastatic secondary brain tumors | [208, 209] |
|
Cisplatin | Platinum-containing anticancer drugs | Liposome | Transferrin-modified cisplatin liposome Cis-lipo(Tf) | IV | Glioma, medulloblastoma, and other types of brain tumors | [210] |
|
Carboplatin | Platinum-based antineoplastic agents | Liposomes | Liposomal carboplatin | IV | Glioma, medulloblastoma, and other types of brain tumors | [211] |
|
Methotrexate | Antimetabolite and antifolate | Nanoparticle | Magnetic nanoparticles | Oral/injection | Malignant brain tumors, brain lymphoma | [212] |
|
Etoposide (ETP) | Topoisomerase inhibitor | Nanoparticle | ETP-encapsulated cationic solid lipid nanoparticles (ETP-CASLNs) grafted with 5-HT-moduline | IV/oral | Malignant brain tumors | [213] |
Liposomal etoposide | | | [211] |
|
Actinomycin (dactinomycin) | Polypeptide antibiotics | Liposome | Liposome encapsulated actinomycin | IV | Secondary brain tumor, child brain tumor | [214] |
|
Irinotecan | DNA topoisomerase I inhibitor | Liposome | Nanoliposomal irinotecan | IV | Glioblastoma multiforme | [215] |
|
Paclitaxel (Taxol) |
Taxanes | Chemical | Tx-67,10-O-deacetylpaclitaxel 10-monosuccinyl ester | | | [216] |
Liposomes | Polysorbate 80 coated poly (-caprolactone)-poly (ethylene glycol)-poly (-caprolactone) (PCEC) micelles | IV | High grade glioma, oligodendroglioma | [217] |
Paclitaxel plus artemether liposomes | | | [218] |
|